SCHEMBL127190

SCHEMBL127190

COC[C@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL856592 1.00
Hydrochloric Acid SCHEMBL1485343 1.00
SCHEMBL127189 1.00
SCHEMBL993593 1.00
Hydrochloric Acid SCHEMBL10988485 1.00
Phosphoric Acid SCHEMBL4422997 0.91 NOS3 (0.44)
SCHEMBL9179525 0.87 NOS3 (0.50)
SCHEMBL9179523 0.87 NOS3 (0.50)
Trifluoroacetic Acid SCHEMBL2321048 0.87 NOS2 (0.42)
SCHEMBL5606478 0.84 NOS3 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2244 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4740955-A2 NOVEL GLP-1 ANALOGUES Sun Pharmaceutical Industries Limited (IN) 2026-05-13 EP claimed
EP-4724471-A1 GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS Sun Pharmaceutical Industries Limited (IN) 2026-04-15 EP claimed
EP-4724472-A2 GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS Sun Pharmaceutical Industries Limited (IN) 2026-04-15 EP claimed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
EP-4720086-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
US-20260062447-A1 COMPOUNDS UNIV SOUTHAMPTON (GB) 2026-03-05 US claimed
EP-4610269-A1 UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE 3B Pharmaceuticals GmbH (DE) 2025-09-03 EP claimed
EP-4577555-A1 COMPOUNDS UNIVERSITY OF SOUTHAMPTON (GB) 2025-07-02 EP claimed
WO-2025099047-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) BICYCLETX LIMITED (GB) 2025-05-15 WO claimed
WO-2025064641-A1 SYNTHETIC COMPOUNDS COMPRISING DIHYDROISOQUINOLINONE MONOMERS SRI INTERNATIONAL (US) 2025-03-27 WO claimed
EP-0564561-A4 PEPTIDES KETOAMIDES, KETOACIDS, AND KETOESTERS GEORGIA TECH RES INST (US) 1994-08-10 EP claimed
US-5306824-A Enzyme inhibitors; purifying proteins GEORGIA TECH RESEARCH CORPORATION (US) 1994-04-26 US claimed
EP-0564561-A1 PEPTIDES KETOAMIDES, KETOACIDS, AND KETOESTERS GEORGIA TECH RESEARCH CORPORATION (US) 1993-10-13 EP claimed
WO-1992012140-A1 PEPTIDES KETOAMIDES, KETOACIDS, AND KETOESTERS GEORGIA TECH RESEARCH CORPORATION (US) 1992-07-23 WO claimed
EP-0226304-B1 COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC SANKYO COMPANY LIMITED (JP) 1991-08-28 EP claimed
US-4757066-A Reduces renal toxicity SANKYO COMPANY LIMITED (JP) 1988-07-12 US claimed
EP-0226304-A1 Composition containing a penem or carbapenem antibiotic SANKYO COMPANY LIMITED (JP) 1987-06-24 EP claimed
EP-0175180-A1 Histargin-related compounds, a process for their preparation and their use as medicaments MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 1986-03-26 EP claimed
EP-0105193-A2 Spergualin-related compounds, processes for the preparation thereof and their use as medicaments MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 1984-04-11 EP claimed
US-4199568-A Tetrapeptide amides RECKITT & COLMAN PRODUCTS LIMITED (GB) 1980-04-22 US claimed